| 334 |
Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration |
Alexander Cole |
BY-SA |
122: Increase, Glucocorticoid receptor activation
|
360: Decrease, Population growth rate
|
|
|
| 335 |
AOP for urothelial carcinogenesis due to chemical cytotoxicity by mitochondrial impairment |
Nathalia Pereira Souza |
BY-SA |
177: Increase, Mitochondrial dysfunction
|
1763: Urothelial Tumor
|
|
|
| 338 |
DNA methyltransferase inhibition leading to population decline (3) |
You Song |
BY-SA |
1619: Increase, DNA methyltransferase inhibition
|
2 AOs
|
|
|
| 420 |
Aryl hydrocarbon receptor activation leading to lung cancer through sustained NRF2 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
None
|
|
|
| 435 |
Deposition of ionising energy leads to population decline via pollen abnormal |
Li Xie |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 433 |
hERG channel blockade leading to sudden cardiac death |
Egemen Bilgin |
BY-SA |
2099: hERG channel blockade
|
1964: Sudden cardiac death
|
|
|
| 432 |
Deposition of Energy by Ionizing Radiation leading to Acute Myeloid Leukemia |
Dag Anders Brede |
BY-SA |
1686: Deposition of Energy
|
1955: Acute Myeloid Leukemia
|
|
|
| 431 |
Increased tumor necrosis factor (TNF) leading to increased risk of gestational diabetes mellitus (GDM) |
Qi Wang |
BY-SA |
1950: Increase, TNF
|
1953: Gestational diabetes mellitus
|
|
|
| 429 |
A cholesterol/glucose dysmetabolism initiated Tau-driven AOP toward memory loss (AO) in sporadic Alzheimer's Disease with plausible MIE's plug-ins for environmental neurotoxicants |
Erwin L Roggen |
BY-SA |
None
|
1941: Memory Loss
|
|
|
| 427 |
ACE2 downregulation following SARS-CoV-2 infection triggers dysregulation of RAAS and can lead to heart failure. |
Evangelos-Panagiotis Daskalopoulos |
BY-SA |
1739: Binding to ACE2
|
1535: Heart failure
|
|
|
| 426 |
SARS-CoV-2 spike protein binding to ACE2 receptors expressed on pericytes leads to endothelial cell dysfunction, microvascular injury and myocardial infarction. |
Evangelos-Panagiotis Daskalopoulos |
BY-SA |
1739: Binding to ACE2
|
1934: Myocardial Infarction
|
|
|
| 425 |
Oxidative Stress Leading to Decreased Lung Function via Decreased FOXJ1 |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 424 |
Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 421 |
PPARG activation leading to intrahepatic cholestasis |
Yuan Jin |
BY-SA |
None
|
None
|
|
|
| 419 |
Aryl hydrocarbon receptor activation leading to impaired lung function through P53 toxicity pathway |
Dianke Yu |
BY-SA |
None
|
1250: Decrease, Lung function
|
|
|
| 405 |
Organo-Phosphate Chemicals induced inhibition of AChE leading to impaired cognitive function |
SAROJ AMAR |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
402: Cognitive function, decreased
|
|
|
| 406 |
SARS-CoV-2 infection leading to hyperinflammation |
Hasmik Yepiskoposyan |
BY-SA |
1739: Binding to ACE2
|
1868: Hyperinflammation
|
|
|
| 407 |
SARS-CoV-2 infection leading to pyroptosis |
Hasmik Yepiskoposyan |
BY-SA |
1739: Binding to ACE2
|
1967: Pyroptosis
|
|
|
| 409 |
Frustrated phagocytosis leads to malignant mesothelioma |
Penny Nymark |
BY-SA |
1668: Frustrated phagocytosis
|
1090: Increased, mesotheliomas
|
|
|
| 410 |
GSK3beta inactivation leading to increased mortality via defects in developing inner ear |
Vid Modic |
BY-SA |
1647: GSK3beta inactivation
|
2 AOs
|
|
|
| 411 |
Oxidative stress Leading to Decreased Lung Function |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 413 |
Oxidation and antagonism of reduced glutathione leading to mortality via acute renal failure |
Carmel Mothersill |
BY-SA |
926: Oxidation, Glutathione (To be considered with MIE)
|
351: Increased Mortality
|
|
|
| 414 |
Aryl hydrocarbon receptor activation leading to lung fibrosis through TGF-β dependent fibrosis toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
None
|
|
|
| 415 |
Aryl hydrocarbon receptor activation leading to lung fibrosis through IL-6 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
1276: Lung fibrosis
|
|
|
| 416 |
Aryl hydrocarbon receptor activation leading to lung cancer through IL-6 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
1670: Lung cancer
|
|
|